Event Calendar
Upcoming Events
There are no currently no events scheduled.
Past Events
-
Tuesday, March 09, 2021 - Wednesday, March 10, 2021
H.C. Wainwright Global Life Sciences ConferenceAdd to Calender -
Monday, January 11, 2021 6:00 am EST
H.C. Wainwright Bioconnect 2021 ConferenceAdd to Calender -
Thursday, November 12, 2020 3:30 pm EST
H.C. Wainwright 6th Annual Israel ConferenceAdd to Calender -
Thursday, September 17, 2020 2:40 pm EDT
Cantor Fitzgerald Virtual Global Healthcare ConferenceAdd to Calender -
Monday, September 14, 2020 5:00 pm EDT
H.C. Wainwright 22nd Annual Global Investment ConferenceAdd to Calender -
Tuesday, May 05, 2020 3:45 pm EDT
Bellerophon Therapeutics Participate in COVID-19 Panel at Maxim Group’s Infectious Disease Virtual ConferenceDescription http://go.pardot.com/l/652223/2020-04-02/j1mqg – Attendees are required to RSVP in order to participate. Attendees not representing an institution must also meet individual criteria outlined in the RSVP process.
Add to Calender -
Tuesday, March 31, 2020 1:00 pm EDT
Investor Call on INOpulse® for the Treatment of COVID-19, hosted by Bellerophon TherapeuticsSupporting Materials COVID 19 Overview 1.2 MBAdd to Calender -
Tuesday, December 17, 2019 8:30 am EST
Bellerophon Conference Call to Discuss Top-line Results from Cohort 2 of the Company's Ongoing Phase 2/3 iNO-PF trialSupporting Materials iNO-PF Cohort 2 Top-line Data 709.2 KBAdd to Calender -
Tuesday, September 10, 2019 2:10 pm EDT
Bellerophon Therapeutics Inc. at the H.C. Wainwright 21st Annual Global Investment ConferenceAdd to Calender -
Thursday, June 20, 2019 11:00 am EDT
Bellerophon Therapeutics Inc. at the JMP Securities Life Sciences ConferenceDescription Click Here for more JMP Conference information
Add to Calender -
Wednesday, May 29, 2019 12:00 pm EDT
Key Opinion Leader (KOL) meetingAdd to Calender -
Wednesday, September 05, 2018 9:10 am EDT
Bellerophon Therapeutics Inc. at the Rodman & Renshaw 20th Annual Global Investment Conference -
Wednesday, June 20, 2018 9:00 am EDT
Bellerophon Therapeutics Inc. Clearside Biomedical, Inc. at the 2018 JMP Securities Life Sciences Conference